Alterity Therapeutics (PRNAD) Cash from Discontinued Operations (2009 - 2016)
Alterity Therapeutics (PRNAD) posted quarterly Cash from Discontinued Operations of 465813.11 for Q4 2016, up 85.85% on a QoQ basis from 3291344.0 in Q4 2010.
Alterity Therapeutics (PRNAD) Cash from Discontinued Operations (2009 - 2016) Analysis & Trends
Alterity Therapeutics (PRNAD) has reported Cash from Discontinued Operations for 3 consecutive years, with 465813.11 the latest figure, recorded in Q4 2016.
- In Q4 2016, Cash from Discontinued Operations changed N/A year-over-year to 465813.11; the TTM figure through Dec 2016 stood at 3757157.11 (up 23.18% YoY), while the FY2012 annual figure was 6916692.91, down 42.92% from the prior year.
- Cash from Discontinued Operations came in at 465813.11 for Q4 2016 at Alterity Therapeutics, up from 3291344.0 in the prior quarter.
- The five-year high for Cash from Discontinued Operations was 465813.11 in Q4 2016, with the low at 465813.11 in Q4 2016.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2016 | -465,813.11 |
| Dec 31, 2016 | -465,813.11 |
| Dec 31, 2010 | -3.29 Mn |
| Dec 31, 2010 | -3.29 Mn |
| Dec 31, 2009 | -1.60 Mn |
| Dec 31, 2009 | -1.60 Mn |